ICON plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc -0.26%93.275.5%$179.13m
VRXValeant Pharmaceuticals International, Inc. -0.86%30.0414.1%$176.76m
ICLRICON plc -0.36%204.474.2%$131.48m
CTLTCatalent, Inc. -0.40%110.552.1%$123.68m
GWPHGW Pharmaceuticals Plc 0.04%218.906.1%$117.99m
UTHRUnited Therapeutics Corp. 1.02%203.7314.1%$97.91m
JAZZJazz Pharmaceuticals Plc 0.30%168.902.3%$91.17m
BHCBausch Health Cos., Inc. -0.86%30.040.0%$90.58m
SAVACassava Sciences, Inc. -0.68%34.850.0%$53.32m
ARGXargenx SE 1.53%281.720.0%$51.68m
PRGOPerrigo Co. Plc 1.14%41.646.9%$37.87m
SAGESAGE Therapeutics, Inc. -1.14%74.647.6%$36.56m
PCRXPacira Biosciences, Inc. -4.93%63.079.9%$28.43m
AMRNAmarin Corp. Plc 0.20%5.021.5%$27.84m
ICPTIntercept Pharmaceuticals, Inc. -1.31%20.2816.8%$26.02m

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.